Skip to main content
Caplight Logo









Amend Surgical

Amend Surgical

Private
Alachua, FloridaHealthcare & Life Scienceshttps://www.amendsurgical.com/

Last Round

Grant

May 4, 2022

Total Funding Raised

$500,000

Company Overview

Amend Surgical is a medical device company that develops and manufactures novel orthobiologics and biomaterials to enhance bone healing and wound closure for the orthopedic, spine, and dental surgery fields.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthobiologicsbiomaterialsbone graft substitutesuture alternativehydrogel adhesivesurgical adhesivedemineralized bone matrixDBMbioactive glasstissue tapespine surgery devicesorthopedic surgery devicesdental surgery devicessynthetic bone graftperipheral nerve repairresorbable membrane

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amend Surgical Comparables

Compare Amend Surgical with similar companies based on industry and business-model similarity.

Amend Surgical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synergy Biomedical, LLC
85%
RevBio, Inc.
83%
Tissium
77%

Amend Surgical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 4, 2022
GrantMay 18, 2017
SeedApr 15, 2016

Key People

Founding team and executive leadership

Robby Lane

CEO and President

Executive Team

Amend Surgical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 75% MoM, from 1.1K to 1.9K.

  • May 2, 2025

    Monthly visitors increased 75% MoM, reaching 1.3K.

Recent news

Latest coverage and updates

  • is_developingAug 10, 2026

    Amend Surgical is developing NanoFUSE Bioactive Plug on Aug 10th '26.

  • partners_withAug 10, 2026

    Amend Surgical partnered with MLM Biologics Inc. on Aug 10th '26.

Amend Surgical Filings

Explore SEC and related filing metadata, where available.

Amend Surgical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amend Surgical's valuation, stock price, and market status.

Is Amend Surgical a public or private company?

Amend Surgical is a private company.

What is the current stock price of Amend Surgical?

Amend Surgical is a private company with no public stock price. No recent secondary market data is available.

How much is Amend Surgical worth (valuation)?

Valuation information for Amend Surgical is not publicly available.

Can I buy Amend Surgical stock?

Amend Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amend Surgical's last funding round?

Funding round information for Amend Surgical is not publicly available.

Who are the main investors in Amend Surgical?

Investor information for Amend Surgical is not publicly disclosed.

Will Amend Surgical IPO soon?

No public IPO plans have been announced for Amend Surgical.

How can I track Amend Surgical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amend Surgical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAlachua, Florida
Employee Range8
Year Founded2015
Last FundingMay 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?